Welcome to CREATE Health
Our vision: To contribute with innovative diagnostics and therapeutic solutions not for coming generations but for today's
CREATE Health aims to provide individualized and improved therapeutic strategies, based on our ability to determine which patient will benefit from a particular treatment. CREATE Health provides solutions to clinical problems by developing innovative diagnostic and therapeutic ideas , for the benefit of the patients and society.
News
Promising results for Lead Biologics’ first-in-class checkpoint inhibitor published in Nature Cancer
Lead Biologics takes a major step towards a new cancer treatment. A new study shows that the company’s drug candidate effectively inhibits a previously unknown immune escape mechanism and eliminates acute myeloid leukemia cells in advanced experimental models.
– This confirms the great interest in our novel approach to treating cancer, and is an important step towards first-in-human studies, says Anki Malmborg Hager, CEO at Lead Biologics.
The discovery that is now published in Nature Cancer is based on research from Lund University led by professor Thoas Fioretos who is also one of the founders of Lead Biologics and one of CREATE Health Principle Investigators.